BioHarvest Sciences Inc. (BHST) stock
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.30−0.02 (-1.52%)
Close on Nov 20, 2026Market cap $29.47MP/E –Yield –
BioHarvest Sciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was $20.48M, up 46.9% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.48M | +46.9% |
| FY2024 | Dec 31, 2024 | $13.94M | +147.5% |
| FY2023 | Dec 31, 2023 | $5.63M | – |
See a number that looks wrong?